澳洲生物巨头CSL拟裁员3000人，股价大跌15%

Core Viewpoint - CSL, an Australian biotechnology giant, announced the spin-off of its vaccine division and plans to lay off approximately 3,000 employees, which represents 15% of its total workforce [1] Group 1 - CSL's stock price dropped by as much as 15% in the afternoon trading session, potentially marking the largest single-day decline in its history [1]